Trademark: 87676271
Status Date
Monday, December 6, 2021
Filing Date
Wednesday, November 8, 2017
Published for Opposition
Tuesday, September 4, 2018
Abandoned Date
Monday, December 6, 2021
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
Dec 6, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 6, 2021
Abandonment - No Use Statement Filed
Nov 10, 2021
Teas Change Of Correspondence Received
Nov 10, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Nov 10, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 10, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 29, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 28, 2021
Extension 5 Granted
Apr 14, 2021
Extension 5 Filed
Apr 28, 2021
Case Assigned To Intent To Use Paralegal
Apr 14, 2021
Teas Extension Received
Oct 28, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 26, 2020
Extension 4 Granted
Oct 26, 2020
Extension 4 Filed
Oct 26, 2020
Teas Extension Received
Apr 30, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 28, 2020
Extension 3 Granted
Apr 28, 2020
Extension 3 Filed
Apr 28, 2020
Teas Extension Received
Oct 23, 2019
Teas Change Of Correspondence Received
Oct 25, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 23, 2019
Extension 2 Granted
Oct 23, 2019
Extension 2 Filed
Oct 23, 2019
Teas Extension Received
Apr 26, 2019
Notice Of Approval Of Extension Request E-Mailed
Apr 24, 2019
Extension 1 Granted
Apr 24, 2019
Extension 1 Filed
Apr 24, 2019
Teas Extension Received
Oct 30, 2018
Noa E-Mailed - Sou Required From Applicant
Sep 4, 2018
Official Gazette Publication Confirmation E-Mailed
Sep 4, 2018
Published For Opposition
Aug 15, 2018
Notification Of Notice Of Publication E-Mailed
Jul 27, 2018
Approved For Pub - Principal Register
Jul 26, 2018
Teas/Email Correspondence Entered
Jul 26, 2018
Correspondence Received In Law Office
Jul 26, 2018
Teas Response To Office Action Received
Feb 21, 2018
Notification Of Non-Final Action E-Mailed
Feb 21, 2018
Non-Final Action E-Mailed
Feb 21, 2018
Non-Final Action Written
Feb 21, 2018
Assigned To Examiner
Nov 17, 2017
New Application Office Supplied Data Entered In Tram
Nov 11, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
